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We have shown that A1 adenosine receptors (A1ARs) are
cytoprotective against renal tubular necrosis and apoptosis
both in vivo and in vitro. To study the role of A1AR numbers
on renal epithelial cell survival, we stably overexpressed the
human A1 receptor in a porcine renal tubule cell line and
utilized primary cultures of proximal tubules obtained from
A1AR knockout mice. Receptor-overexpressing cells were
protected against peroxide-induced necrosis and tumor
necrosis factor-a/cycloheximide-induced apoptosis.
Conversely, cultured proximal tubule cells from receptor
knockout mice showed more necrotic and apoptotic cell loss
than corresponding cells from wild-type mice.
Overexpression of the receptor resulted in a significantly
higher baseline expression of both total and phosphorylated
heat-shock protein (HSP)27; the latter due to A1 receptor
enhancement of p38 and AP2 mitogen-activated protein
kinase activities. The resistance to cell death in the porcine
cells was reversed by selective A1 receptor antagonism and
by a selective inhibitor of HSP synthesis. Receptor activation
in wild-type mice in vivo led to increased total and
phosphorylated HSP27, whereas receptor knockout mice
showed decreased baseline and adenosine-mediated HSP
phosphorylation. These studies show that endogenous A1AR
activation produces cytoprotective effects in renal proximal
tubules by modulating HSP27 signaling pathways.
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Acute renal failure after ischemia and reperfusion (IR) injury
is a frequent cause of mortality and morbidity during the
perioperative period. We have previously demonstrated that
A1 adenosine receptor (A1AR) activation protects against
renal IR injury in both in vivo and in vitro models via
mechanisms involving Gi, PKC, and extracellular signal-
regulated kinase (ERK) activation.1–3 We also demonstrated
that mice lacking the A1AR showed increased necrosis,
apoptosis, and inflammation after renal IR injury.4 The
protective effects were due to direct renal tubular effects as
A1AR activation produced direct cytoprotection in renal
tubule cells in vitro.3,5
Typical of G-protein-coupled receptors, A1AR density is
subject to up- and downregulation: chronic agonist or
antagonist stimulation leads to up or downregulation of
A1ARs, respectively, in several organs including the kidney.
6–8
We have previously demonstrated that chronic treatments
with a non-selective AR agonist abolished the protective
effects of adenosine in a human proximal tubule cell line
(HK-2) against hydrogen peroxide (H2O2)-mediated injury.
5
Moreover, chronic treatments with a non-selective AR
antagonist in HK-2 cells increased the endogenous tolerance
to H2O2. However, the cellular mechanism(s) of these
changes in sensitivity to oxidant injury was not investigated.
In addition, with the pharmacological modulation of A1AR,
the degree of up- or downregulation of A1AR was modest.
Heat-shock proteins (HSPs) are recognized molecular
chaperones and function as cytoprotective proteins.9 HSPs
protect other intracellular proteins from denaturation and
aggregation that occur in response to oxidative stress. HSP27,
HSP32 (also known as heme oxygenase-1 (HO-1)), and
HSP70 have been implicated in mediating cytoprotection in a
variety of cell types.9,10 Therefore, we investigated whether
expression of HSPs is altered with changes in A1AR
expression in this study.
In this study, we aimed (1) to determine whether genetic
modulation of A1AR receptor expression affects renal tubule
cell survival against necrosis and apoptosis, and (2) to
determine the mechanism(s) of modulation of proximal
tubule survival with modulation of A1AR expression. We
stably overexpressed the human A1AR in a porcine tubule cell
line (LLC-PK1) to study whether upregulation of the A1AR
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effected cytoprotection and expression of HSPs. We also
studied primary cultures of proximal tubules from A1AR
knockout (KO) mice to study the effects of A1AR deletion.
RESULTS
A1AR overexpressing LLC-PK1 cells
We initially evaluated the level of A1AR expression with
radioligand binding assays (with [3H]-1,3-dipropyl-8-cyclo-
pentylxanthine (DPCPX)) which demonstrated robust upre-
gulation of A1AR in A1AR-GFP-LLC-PK1 (A1AR-GFP) cells
compared to green fluorescent protein (GFP)-transfected
cells (GFP). The Bmax of A1AR for the A1AR-GFP cells was
B118-fold higher (Bmax¼ 20027195 fmol/mg protein,
N¼ 5) compared to GFP vector-transfected control LLC-
PK1 (Bmax¼ 1771 fmol/mg protein, N¼ 5, Po0.01).
A1AR overexpression results in increased resistance to
necrosis and apoptosis
The A1AR-overexpressing LLC-PK1 cells showed increased
baseline resistance against necrosis induced with 1 mM to
1 mM H2O2 (Figure 1), as they released significantly less
lactate dehydrogenase (LDH) in a dose- (Figure 1a) and
time-dependent (Figure 1b) manner after H2O2 injury. For
example, A1AR-overexpressing LLC-PK1 cells released
11.672.3% (N¼ 6) total cellular LDH after 2 h with
100 mM H2O2 compared with 34.173.3% for GFP-over-
expressing LLC-PK1 cells (N¼ 6, Po0.01). Overexpression
of A1AR also significantly attenuated apoptosis in LLCPK1
cells (Figure 2). We assessed the degree of apoptosis in LLC-
PK1 cells by measuring caspase 3 and poly ADP-ribose
polymerase (PARP) fragmentation by immunoblotting (Fig-
ure 2a), DNA laddering (Figure 2b), and cytochrome c release
from the mitochondria by immunoblotting (Figure 2c).
These indices of apoptosis show reduced apoptosis following
tumor necrosis factor-a (TNF-a)/cycloheximide in A1AR-
overexpressing LLC-PK1 cells.
Chronic A1AR antagonism or A1AR deletion increases
sensitivity to necrosis and apoptosis
Irreversible blockade of A1AR with 1-propyl-3-[3-[[4-(fluor-
osulfonyl)benzoyl]oxy]-propyl]-8-cyclopentylxanthine
(FSCPX) (20 mM for 48 h) prevented the increased resistance
against necrosis (Figure 3a) and apoptosis (Figure 3b and c)
in A1AR-overexpressing LLC-PK1 cells. Similar to these
findings, 48 h treatment with DPCPX, a selective but
reversible antagonist for A1AR, also prevented the cytopro-
tective benefit of A1AR overexpression and reduced upregu-
lation of HSP27 (data not shown).
We also subjected primary cultures of renal proximal
tubule cells from A1AR wild-type (WT) and A1AR KO mice
to necrosis (with H2O2) and apoptosis (with TNF-a and
cycloheximide). We noted that the primary cultures of
proximal tubule cells from mouse are much harder to kill
with H2O2 when compared to LLC-PK1 cells. Figure 4 shows
that the primary cultures of A1AR KO proximal tubules
released significantly more LDH in response to H2O2 necrosis
in a dose- (Figure 4a) and time-dependent (Figure 4b)
manner compared with the A1AR WT proximal tubules. For
example, A1AR KO cells released 34.3671.9% (N¼ 6) total
cellular LDH after 5 h with 5 mM H2O2 compared with
11.971.7% for A1AR WT cells (N¼ 6, Po0.01). In addition,
the A1AR KO proximal tubules were more susceptible to
apoptotic cell death after TNF-a plus cycloheximide treat-
ment illustrated by enhanced DNA laddering (Figure 4c).
A1AR KO proximal tubules also showed increased caspase 3/
PARP fragmentation in response to TNF-a plus cyclohex-
imide treatment (Figure 10d).
Endogenous and exogenous A1AR activation results in
increased mRNA and protein synthesis of HSP27 in renal
tubules
In order to determine the mechanism(s) of increased
resistance against necrosis and apoptosis in cells over-
expressing A1AR, we performed immunoblotting for several
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Figure 1 | Overexpression of the A1AR-GFP in LLC-PK1 cells
produces cytoprotection against necrosis induced with H2O2. (a)
Dose- (LDH release was examined at 2 h) and (b) time-dependent
cytoprotection against H2O2-induced necrosis (n¼ 6). *Po0.05
compared to GFP LLC-PK1 cells.
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HSPs in A1AR-GFP and GFP-LLC-PK1 cells. HSP27 mRNA
(Figure 5a) and protein (Figure 5b) expression is increased
(Po0.05) in A1AR-overexpressing LLC-PK1 cells (N¼ 6).
HSP32 (HO-1) and HSP70 expression did not change in
A1AR-overexpressing LLC-PK1 cells (data not shown).
Moreover, A1AR activation with 2-chloro-N6-cyclopentyla-
denosine (CCPA), a selective A1AR agonist, caused increased
HSP27 mRNA in A1AR-GFP and GFP-LLC-PK1 cells (Figure
6a, N¼ 5, Po0.05) and primary cultures of proximal tubules
from A1AR WT mice (data not shown). CCPA failed to
increase HSP27 mRNA in A1AR KO proximal tubules (data
not shown). CCPA treatment increased HSP27 protein
expression in GFP-LLC-PK1 cells (Figure 6b, N¼ 5,
Po0.05).
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Figure 2 | Overexpression of the A1AR-GFP in LLC-PK1 cells produces cytoprotection against apoptosis induced with TNF-a plus
cycloheximide. (a) (upper panel) Representative immunoblot image of fragmentation of PARP or caspase 3 induced by TNF-a plus
cycloheximide as compared to vehicle (V) which was attenuated in A1AR-GFP-overexpressing LLC-PK1 cells compared to control cells
(GFP-overexpressing LLC-PK1 cells). (lower panel) Relative band intensities from immunoblots of fragmented PARP or caspase 3 (n¼ 6)
(*Po0.05 compared to GFP-LLC-PK1 cells treated with TNF-a plus cycloheximide (CXM)). (b) Representative gel image of internucleosomal
DNA fragmentation induced by TNF-a plus cycloheximide illustrating less DNA fragmentation in A1AR-GFP-overexpressing LLC-PK1 cells.
(c) (upper panel) Representative immunoblot image illustrating the translocation of cytochrome c from mitochondrial to cytosolic fractions
induced by TNF-a plus cycloheximide and attenuation in A1AR-GFP-overexpressing LLC-PK1 cells. (lower panel) Relative band intensities from
immunoblots of cytosolic cytochrome c (n¼ 6) (*Po0.05 compared to vehicle-treated GFP LLC-PK1 cells).
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A1AR activation phosphorylates HSP27, p38 MAPK, and
MAPKAP2
The A1AR-overexpressing LLC-PK1 cells had higher basal
expression of phospho-HSP27 (Figure 7, N¼ 8, Po0.05). In
addition, CCPA (a selective A1AR agonist) rapidly (within
30 min) caused increased phosphorylation of HSP27 (Fig-
ure 7). Enhanced phosphorylation of HSP27 could be due to
either increased total HSP27 expression and/or due to
increased signaling for the phosphorylation of HSP27 via
upstream kinases (MAPK-activated protein kinase-2 (MAP-
KAP2) and p38 MAPK) of HSP27. The p38 MAPK
phosphorylates HSP27 via MAPKAP2 in non-renal cells.11
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Figure 3 | A1AR antagonist attenuate protection from necrosis and apoptosis in A1AR-LLC-PK1 cells. (a) Endogenous protection against
H2O2 (500mM, 2 or 4 h)-induced necrosis (as percent LDH release) in A1AR-GFP LLC-PK1 cells is blocked by 48 h pretreatment with the
irreversible A1AR antagonist FSCPX (20 mM) (n¼ 6) (*Po0.05 compared to A1AR-GFP LLC-PK1 cells treated with FSCPX). (b) Representative
(of six) gel image of DNA laddering illustrating the loss of endogenous protection against TNF-a plus cycloheximide (CXM)-induced apoptosis
in A1AR-GFP-overexpressing LLC-PK1 cells by chronic exposure (48 h) to FSCPX (20 mM). (c) Increased resistance to apoptosis A1AR-GFP
LLC-PK1 cells is blocked by 48 h pretreatment with 20 mM FSCPX (n¼ 4). Top: representative blots from four independent experiments
performed. Densitometric quantifications of unfragmented PARP (middle) and caspase 3 (bottom) from GFP- and A1AR-GFP-overexpressing
LLC-PK1 cells treated with vehicle, TNF-a plus cycloheximide or TNF-a plus cycloheximide plus FSCPX. *Po0.05 vs GFP-overexpressing cells
treated with vehicle, #Po0.05 vs A1AR-GFP-overexpressing cells treated with vehicle.
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To study upstream signaling intermediates of HSP27 phos-
phorylation in renal tubule cells, we probed for the
phosphorylated forms of p38 MAPK and MAPKAP2. Figure
8a (N¼ 4) shows that 1mM CCPA caused phosphorylation of
both p38 MAPK and MAPKAP2 in GFP-LLC-PK1 cells.
Inhibition of p38 MAPK with SB-203580 (an inhibitor of p38
MAPK) inhibited phosphorylation of p38 MAPK in response
to 1mM CCPA in both GFP- and A1AR-GFP-overexpressing
cells (Figure 8b, N¼ 3, Po0.5). However, even in the presence
of SB-203580, pHSP27 expression in A1AR-GFP-overexpres-
sing cells was greater (although reduced compared to baseline
pHSP27 expression) compared to GFP-expressing cells
indicating that inhibition of CCPA-mediated HSP27 phos-
phorylation was incomplete in the presence of SB-203580
(Figure 8b). Therefore, these data suggest that the increased
amount of phosphorylated HSP27 in A1AR-overexpressing
cells is due to the increased A1AR-p38 MAPK-MAPKAP2
pathway as well as due to a p38 MAPK-independent pathway.
Phosphorylation of ERK or Akt is not altered with A1AR
overexpression or deletion
ERK and/or Akt activation are potential targets of A1AR
activation as we have demonstrated previously.3,12 However,
there were no differences in the amount or the time course of
ERK or Akt phosphorylation in A1AR-GFP and GFP-LLC-
PK1 cells and primary cultures of proximal tubules from
A1AR WT and A1AR KO mice at baseline or with CCPA
treatment (1 mM for 0–16 h, data not shown).
HSP27 is responsible for cytoprotection with A1AR over-
expression
FSCPX, a selective and irreversible antagonist of A1AR,
treatment for 48 h reversed the upregulation of HSP27 mRNA
(Figure 9a) and protein (Figure 9b) in A1AR-overexpressing
LLC-PK1 cells without an effect on the mRNA or protein for
HSP70. We also treated the A1AR-overexpressing LLC-PK1
cells with N-formyl-3,4-methylenedioxy-benzylidene-gamma-
butyrolactam (KNK-437), a specific inhibitor of HSP
synthesis including HSP27.13,14 KNK-437 inhibits all HSP
(not solely HSP27), but has minimal effect on the synthesis of
non-HSP proteins. We confirmed that KNK-437 treatment
significantly attenuated the upregulation of total as well as
phosphorylated HSP27 in A1AR-overexpressing LLC-PK1
cells (data not shown). Figure 10 shows that KNK-437
treatment for 16 h prevented the increased resistance against
necrosis induced with H2O2 (Figure 10a) as well as apoptosis
induced with TNF-a plus cycloheximide (Figure 10b) in
A1AR-GFP-overexpressing LLC-PK1 cells.
We also determined the effects of chronic KNK-437
treatment on necrotic and apoptotic cell death in primary
cultures of proximal tubules from A1AR WT and A1AR KO
mice. We show that KNK-437 negated the increased
resistance to necrosis (Figure 10c) and apoptosis (Figure
10d) in A1AR WT proximal tubules when compared to A1AR
KO proximal tubules.
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Figure 5 | Basal levels of HSP27 mRNA and protein are increased
in LLC-PK1 cells overexpressing the A1AR. (a) (upper panel)
Representative gel image of RT-PCR results for mRNA encoding
HSP27 in unstimulated LLC-PK1 cells overexpressing the A1AR-GFP vs
GFP alone. GAPDH mRNA is shown to correct for RNA input in each
sample (lower panel). Quantification of relative band intensities (as
ratio of GAPDH content) of RT-PCR results for HSP27 in A1AR-GFP vs
GFP LLC-PK1 overexpressing cells (n¼ 6) (*Po0.05 compared to
control GFP LLC-PK1 cells). (b) (upper panel) Representative gel
image of immunoblot results for HSP27 protein in unstimulated LLC-
PK1 cells overexpressing the A1AR-GFP vs GFP alone. (lower panel)
Quantification of relative band intensities of immunoblot results for
HSP27 in A1AR-GFP vs GFP LLC-PK1 overexpressing cells (n¼ 6)
(*Po0.05 compared to control GFP LLC-PK1 cells).
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Endogenous and exogenous A1AR activation phosphorylates
HSP27 in vivo
In vivo, A1AR activation in A1AR WT mice (with 0.1 mg/kg
CCPA) led to increased phosphorylation of HSP27 (Figure
11a) as well as increased total HSP27 synthesis (data not
shown). Immunoblotting of pHSP27 in freshly isolated renal
proximal tubules from A1AR WT and A1AR KO mice shows
that proximal tubules of A1AR WT mice had higher
expression of pHSP27 at baseline compared to proximal
tubules of A1AR KO. CCPA further enhanced phosphoryla-
tion of HSP27 in proximal tubule culture of A1AR WT mice
but not in proximal tubule culture of A1AR KO mice (Figure
11b, N¼ 4, Po0.5).
DISCUSSION
The major findings of this study are as follows: (1)
overexpression of A1AR resulted in greater resistance against
necrosis (induced with H2O2) and apoptosis (induced with
TNF-a plus cycloheximide) in LLC-PK1 porcine renal tubule
cells; (2) primary cultures of proximal tubules from A1AR KO
mice showed enhanced necrosis and apoptosis compared to
tubule from A1AR WT mice; (3) endogenous or exogenous
A1AR activation increased mRNA and protein synthesis of
HSP27 in renal tubules; (4) HSP27 upregulation secondary to
A1AR overexpression was involved in renal tubular protection
against necrosis and apoptosis; (5) A1AR activation leads to
increased phosphorylation of HSP27 in mouse proximal
tubules in vivo, and (6) mice lacking A1AR showed reduced
expression of phospho-HSP27.
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Figure 6 | HSP27 mRNA and protein are increased by an A1AR agonist. (a) (upper panel) Representative gel image of RT-PCR results
for mRNA encoding HSP27 in renal proximal tubule cells from LLC-PK1 cells stimulated with the A1AR agonist CCPA for indicated time points.
(lower panel) Quantification of HSP27 mRNA (as ratio of GAPDH content) in A1AR-GFP- or GFP-overexpressing LLC-PK1 cells following
0–16 h of 1 mM CCPA treatment (n¼ 5) (*Po0.05 compared to unstimulated GFP LLC-PK1 cells). (b) Representative gel image of immunoblot
results for HSP27 in LLC-PK1 cells (upper panel) stimulated with the A1AR agonist CCPA for 0–16 h. (lower panel) Quantification of relative
band intensities of HSP27 protein in GFP LLC-PK1 cells following 0–16 h of 1 mM CCPA treatment (n¼ 5) (*Po0.05 compared to baseline
(CCPA 0 h) GFP LLC-PK1 cells).
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We showed in previous in vivo studies that mice lacking
the A1AR show increased renal dysfunction (necrosis and
apoptosis) after IR injury and cecal ligation and puncture
induced sepsis.12,15 In addition, we have previously shown
that exogenous activation of A1AR in vivo and in vitro led to
protection against IR injury and H2O2 injury, respec-
tively.4,5,12 It was previously unknown whether modulation
of A1AR density without exogenous A1AR agonist adminis-
tration affects cytoresistance against necrosis or apoptosis.
Therefore, in this study, we questioned whether overexpres-
sing A1AR would increase resistance against necrosis and
apoptosis in renal proximal tubule cells in culture. We also
questioned whether proximal tubule cells cultured from
A1AR KO mice would show increased sensitivity to necrotic
and apoptotic death.
Renal tubular injury in IR injury or septic shock results in
cell death via necrotic or apoptotic pathways.16,17 One of the
advantages of the in vitro model of renal injury is that the
severity of cellular injury can be modulated so that one form
of cell death (e.g., necrosis) predominates over the other (e.g.,
apoptosis). We induced necrosis with H2O2, which caused
rapid, dose-dependent cell death indicated by LDH released
into the culture media. Treatment with TNF-a plus
cycloheximide resulted in slower cell death, characteristic of
programmed death pathways of apoptosis including distinct
DNA laddering, caspase 3 and PARP fragmentation, and
mitochondrial cytochrome c release.
We demonstrate that LLC-PK1 renal tubule cells over-
expressing A1AR display significant resistance against both
necrosis as well as apoptosis, even without exogenous A1AR
activation. This enhanced protection without any A1AR
stimulation indicates that endogenous adenosine in the cell
culture media provides tonic cytoprotection in these cells via
activation of A1AR, and overexpression of A1AR is sufficient
to cause cytoprotective pathways to become enhanced.
Consistent with this, primary cultures of renal proximal
tubules from mice lacking the A1AR showed increased cell
death responses to H2O2-induced necrosis and TNF-a plus
cycloheximide-induced apoptosis. These findings are signifi-
cant as it may be feasible to produce therapeutic renal
protection by upregulating A1AR expression in the kidney
without exogenous administration of an A1AR agonist and
avoid the potential side effects of systemic A1AR activation.
We show for the first time in this study that over-
expression of A1AR is associated with significantly increased
basal levels of phosphorylated as well as total HSP27. We also
show that an A1AR-selective agonist rapidly phosphorylates
HSP27 via a p38 MAPK-MAPKAP2 pathway. Classically,
activation of p38 MAPK results in activation of MAPK2, a
serine protein kinase that phosphorylates and activates
HSP27.11,18 However, increased pHSP27 expression could
be due to increased total HSP27 protein expression and/or
due to increased activation of an upstream kinase that
phosphorylates HSP27 (p38 MAPK-MAPKAP2/3 path-
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way). p38 MAPK inhibitor studies demonstrate that both
factors contribute to enhanced pHSP27 expression.
We also demonstrate in this study that A1AR activation led
to time- and dose-dependent upregulation of HSP27 mRNA
and protein synthesis in LLC-PK1 cells and in primary
cultures of proximal tubules from A1AR WT mice. We
propose that endogenous A1AR activation coupled with
overexpression of A1AR would lead to increased synthesis of
HSP27 mRNA and protein. Additionally, we demonstrated
that treating mice with a selective A1AR agonist (CCPA) led
to increased phosphorylation of HSP27 in proximal tubules
in A1AR WT mice. Moreover, mice lacking A1AR showed
reduced expression of phospho-HSP27 in proximal tubules.
These data demonstrate that our in vitro findings have direct
relevance in vivo.
HSP27 is a molecular chaperone protein with diverse
cytoprotective effects.19 Van Why et al.20 have demonstrated
that HSP27 associates with the actin cytoskeleton and limits
injury in LLC-PK1 cells. The phosphorylation state of specific
sites on HSP27 may impact its function. Phosphorylation of
HSP27 enhances resistance of actin to breakdown and
maintains cytoskeletal architecture after ATP depletion and
IR injury.21–23 This may be due in part to preservation of
cytoskeletal actin in a filamentous state over a globular state.
Recent reports suggest that HSP27 may also enhance the
biological activity of Akt by acting as a scaffolding protein of
Akt.24–26 Overexpression of phosphorylation-deficient HSP27
has been shown to confer significant cytoresistance against
heat shock, simulated ischemia, proapoptotic agents (i.e.,
TNF-a), oxidant stress, and a number of cytotoxic drugs.27
HSP27 can protect by reducing oxidative stress-mediated
injury, molecular chaperoning by preventing unfolded
proteins from irreversible aggregation, and by counteracting
apoptosis via interacting with caspases and cytochrome c.28,29
We propose that induction of HSP27 and increased
phosphorylation of HSP27 provided powerful in vitro
protection against necrosis as well as apoptosis in renal
proximal tubule cells.
We demonstrate in this study that both a reversible A1AR
antagonist (DPCPX) and an irreversible antagonist of A1AR
(FSCPX) prevented the upregulation of HSP27 and reversed
cytoprotection in A1AR-overexpressing cells. FSCPX forms a
covalent bond with A1AR leading to permanent antagonism
of this receptor. Therefore, chronic antagonism of A1AR can
negate the effects of A1AR overexpression and prevent the
upregulation of HSP27. Therefore, these findings further
support the finding that HSP27 upregulation mediates the
cytoprotective effects of A1AR overexpression.
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We showed that the dose of SB-203580 we used near
completely inhibited phospho-HSP27 phosphorylation in
control (GFP-overexpressing) LLC-PK1 cells treated with
CCPA. We also show that the inhibition of phospho-HSP27
in the A1AR-overexpressing LLC-PK1 cells by SB-203580 is
incomplete (although the phospho-HSP27 expression in
CCPAþ SB-203580-treated cells was reduced below that of
vehicle-treated cells). This may mean that increased pHSP27
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expression in A1AR-overexpressing LLC-PK1 cells are due to
both the A1AR-p38 MAPK pathway as well as a p38 MAPK-
independent pathway. We showed increased total HSP27
expression in A1AR-overexpressing cells. Most likely, in-
creased total HSP27 expression led to increased phospho-
HSP27 expression in these cells and this pathway is
independent of p38 MAPK pathway.
Similar to that observed with p38 MAPK inhibition, we
demonstrated that although DPCPX near completely in-
hibited HSP27 phosphorylation in response to acute CCPA in
control LLC-PK1 cells, it failed to completely attenuate the
HSP27 phosphorylation by CCPA in A1AR-overexpressing
cells. Therefore, chronic A1AR upregulation leading to HSP27
expression results in increased phospho-HSP27, which is not
completely due to endogenous and acute activation of A1AR
but most likely due to an increased amount of total HSP27
and subsequently increased phospho-HSP27. These data
must be differentiated from the experiments with chronic
A1AR antagonism. In these studies, we showed that chronic
inhibition of A1AR prevented upregulation of HSP27 and
phospho-HSP27. Therefore, whereas acute inhibition of
A1AR failed to completely block upregulation of HSP27/
phospho-HSP27, chronic inhibition of A1AR did attenuate
upregulation of HSP27/phospho-HSP27.
We used KNK-437, a benzylidene lactam compound, to
inhibit the induction of HSPs in LLC-PK1 cells stably
transfected with the GFP vector or A1AR-GFP vector. KNK-
437 is a specific, although not selective for a particular form
of HSP, inhibiting HSP induction without inhibiting basal
levels of HSP expression.13,14 Unlike quercetin, an inhibitor
of HSP synthesis, KNK-437 is more specific for the inhibition
of HSP induction without having effects on protein kinase A,
protein kinase C, or tyrosine kinases.13,14,30 We show that
inhibition of HSPs with KNK-437 prevented cytoprotection
with A1AR overexpression. Our KNK-437 experiment further
supports the hypothesis that HSP27 induction is responsible
for cytoprotection with A1AR overexpression and compli-
ments our studies described above that chronic antagonism
of A1AR reversed the cytoprotection and reduced HSP27
overexpression.
It is important to demonstrate that the phenomenon of
A1AR-induced protection and HSP27 upregulation is not a
unique property of a population of cells arising from a single
colony. We generated the A1AR-GFP-overexpressing LLC-
PK1 cells from several colonies surviving in the presence of
G-418 by isolating multiple colonies from a single plate;
therefore, we utilized A1AR-overexpressing LLC-PK1 cells
arising from multiple transformed cells. In preliminary
studies, we determined that HSP27 expression is consistently
elevated in independent cell lines derived from transformed
LLC-PK1 cells. We also generated A1AR-overexpressing
human proximal tubule cells (A1AR HK-2 cells) in a similar
manner. We determined that HK-2 cells overexpressing
A1ARs also show increased expression of HSP27 (data not
shown). Therefore, an increase in HSP27 expression after
A1AR overexpression cannot be due to the peculiarity of a
single clone/cell line.
In summary, our in vitro studies demonstrate that
overexpression or deletion of the A1AR in renal proximal
tubule cells resulted in significant modulation of resistance to
necrosis. Therefore, it appears that endogenous activation of
A1AR results in increased resistance to necrosis and apoptosis
via upregulation of the HSP27 cytoprotective pathway
consistent with our finding that A1AR KO mice show
increased renal dysfunction after IR injury and sepsis.
MATERIALS AND METHODS
Generation of A1AR-overexpressing renal tubule cells in vitro
LLC-PK1 cells (immortalized porcine renal tubule cell line) were
transfected with an A1AR-GFP- or a control GFP-expressing
plasmid31 using Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA) and G-418 resistant colonies overexpressing A1AR-GFP or
GFP alone were manually isolated and propagated. We generated the
A1AR-GFP-overexpressing LLC-PK1 cells from several colonies
surviving in the presence of G-418; therefore, they are mixed
lineage originating from an individual cell line. The LLC-PK1 cells
were cultured in a 50:50 mix of Dulbecco’s modified Eagle’s medium
and F12 plus 5% fetal bovine serum.
Radioligand binding assays for A1ARs
Saturation radioligand binding assays for A1ARs were performed
according to the general procedure as described previously, using
DPCPX (a highly selective A1AR antagonist) as a radioligand.
6,7 In
brief, cell membranes prepared from A1AR-GFP-LLC-PK1 and GFP-
LLC-PK1 cells (50ml, approximately 0.2 mg protein) were incubated
with an equal volume of a solution containing adenosine deaminase
(2 U/ml), CHAPS (0.01%), GTPgS (10 mM), and [3H]-DPCPX
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(109 Ci/mmol, 0.05–3 nM). The incubation was allowed to proceed at
251C for 2 h under gentle shaking, before being terminated by rapid
(o10 s) vacuum filtration through Whatman GF/C glassfiber filters,
presoaked in 0.1% CHAPS to reduce nonspecific binding, and
washed with 15 ml of ice-cold wash buffer – 10 mM tris(hydroxy-
methyl)aminomethane chloride (Tris-Cl), 1 mM MgCl2, pH 7.4.
Radioactivity trapped on the filters (total binding) was measured by
liquid scintillation counting with an efficiency of 50%. Nonspecific
binding, defined as the trapped radioactivity measured after an
incubation with radioligand plus 100mM unlabeled CCPA
(a selective agonist for A1AR), was subtracted from the total
binding to yield the specific binding. Radioligand binding was
repeated every 4 weeks to ensure that overexpression of A1AR
persisted in A1AR-GFP LLC-PK1 cells.
Primary cultures of proximal tubules from A1AR WT and A1AR
KO
Breeding pairs of A1AR heterozygous mice were obtained from Dr
Jurgen Schnermann (NIDDK, NIH) to generate A1AR WT and
A1AR KO mice as described previously.
4 After Columbia University
IACUC approval, A1AR WT or A1AR KO mice were killed with an
overdose of pentobarbital. Kidneys were rapidly removed and the
proximal tubules were enriched using the methods of Vinay et al.32
and cultured in 50:50 mixture of Dulbecco’s modified Eagle’s
medium high glucose and F12 plus 5% fetal bovine serum.
In vivo activation of A1AR in mice
Some A1AR WT and A1AR KO mice were treated with 0.1 mg/kg
CCPA (a selective A1AR agonist). Zero to 24 h later, animals were
killed, renal proximal tubules were isolated as described above and
subjected to phospho-HSP or HSP27 immunoblotting as described
below.
Induction of renal tubule necrosis and apoptosis
All of the following treatments were performed after cells
were maintained for 24 h in serum-free basal media. Renal tubule
cell necrosis was induced with H2O2 (1 mM to 1 mM for LLC-PK1
cells and 1–10 mM for A1AR KO and A1AR WT proximal tubule
cells) for 1–4 h. We determined in preliminary studies that the ability
of H2O2 to kill LLC-PK1 cells is dose- and time related. High
(e.g., 1–10 mM) doses of H2O2 killed cells rapidly (within 1 h),
whereas lower doses (e.g., 1–10 mM) killed cells more slowly. Our
preliminary studies also showed that our treatment with H2O2 (for
1–4 h) causes negligible apoptosis (data not shown). Renal tubule
apoptosis was induced with TNF-a (10 ng/ml) plus cycloheximide
(5mg/ml) for 16 h.
To determine the effect of chronic blockade (reversible or
irreversible) of A1AR in cytoprotection induced by A1AR upregula-
tion, GFP-LLC-PK1 and A1AR-GFP-LLC-PK1 cells were treated
with 2–20 mM of DPCPX (a reversible and selective A1AR antagonist)
or with FSCPX (an irreversible and selective A1AR antagonist)
2 days before subjecting the cells to necrosis and apoptosis.
To determine whether inhibiting the induction of new HSPs
prevents cytoprotection with A1AR upregulation, we treated the
cells with 50 and 100mM of KNK-437, (a selective inhibitor of new
HSP synthesis) for 16 h and subjected the cells to necrosis and
apoptosis. Some cells were treated with A1AR antagonists or the
HSP inhibitor only to determine the effects of these inhibitors on
cell survival.
Measurement of cell viability with LDH
LDH released into cell culture media as indices of cell death were
measured using an LDH assay kit from Promega (Madison, WI,
USA). Released LDH from cells was expressed as a percentage of
total cellular LDH (LDH released into the media following cell lysis
(with 1% triton-X for 5 min)).
Immunoblot analyses
We measured the activation (via phosphorylation) of ERK MAPK
(the extracellular signal-regulated protein kinase mitogen-activated
protein kianse) and Akt (protein kinase B, PKB) by immunoblotting
in A1AR-GFP-LLC-PK1 and GFP-LLC-PK1 cells as described
previously.33,34 Phospho-P38 MAPK, HSP 27, phospho-HSP27,
HO-1, and HSP70 immunoblotting was also performed. The
primary antibodies for phospho-ERK1/2, HSP27, and HO-1
(HSP32) were from Santa Cruz Biotechnologies (Santa Cruz, CA,
USA). Antibodies for phospho-Akt, phospho-MAPKAP2, phospho-
p38 MAPK, and phospho-HSP27 were from Cell Signaling
Technologies (Danvers, MA, USA). The antibody for the inducible
form of HSP70 was from Stressgen Biotechnologies (San Diego, CA,
USA). The secondary antibody (goat anti-rabbit or anti-mouse IgG
conjugated to horseradish peroxidase at 1:5000 dilution) was
detected with enhanced chemiluminescence immunoblotting detec-
tion reagents (Amersham, Piscataway, NJ, USA), with subsequent
exposure to a CCD camera coupled to a UVP Bio-imaging System
(Upland, CA, USA) and a personal computer. The band intensities
of the immunoblots were within the linear range of exposure for all
experiments.
Detection of DNA fragmentation in apoptosis with DNA
laddering
DNA from monolayers of renal tubule cells in culture was extracted
(Wizard, Promega) and was electrophoresed at 70 V in a 2.0%
agarose gel in Tris-acetate-EDTA buffer. The gel was stained with
ethidium bromide and photographed under UV illumination. DNA
ladder markers (100 bp) were added to each gel as a reference for the
analysis of internucleosomal DNA fragmentation.
Detection of PARP, caspase 3 fragmentation, and
mitochondrial cytochrome c release in apoptosis
We also utilized immunoblotting of PARP and caspase 3
fragmentation to detect apoptosis. To detect the release of
cytochrome c from the mitochondria to the cytosol, LLC-PK1 cells
were harvested, resuspended in ice-cold lysis buffer (20 mM HEPES,
pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 2 mg/ml aproti-
nin, 10mg/ml leupeptin), and incubated for 10 min on ice. Cells
were then disrupted in a sonicator for 10 s and centrifuged at 750 g
for 15 min at 41C. The supernatant was centrifuged at 10 000 g for
15 min at 41C and resultant pellet served as the mitochondrial
fraction. The supernatant from the 10 000 g spin was centrifuged at
100 000 g and the resultant supernatant served as the cytosolic
fraction. For PARP and caspase 3 fragmentation, whole cell lysates in
ice-cold lysis buffer were subjected to immunoblotting. Immuno-
blotting was performed as described above. Primary mouse
antibodies for PARP, caspase 3, and cytochrome c were from Santa
Cruz Biotechnologies.
Reverse transcriptase-polymerase reaction
RNA from LLC-PK1 cells was extracted and reverse transcriptase-
polymerase reactions (RT-PCRs) for A1AR, HSP27, HSP32 (HO-1)
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and HSP70, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were performed with the one-step RT-PCR kit as
described previously35,36 (Access RT-PCR System, Promega,
Madison, WI, USA). We used primers designed to recognize
porcine or murine sequences based on sequences of HSP27,
HSP32, HSP70, and GAPDH (Table 1). They were chosen to yield
expected PCR products of 200–600 bp, have 50–60% GC
content, and all span an intron to distinguish products arising
from genomic DNA contamination. Cycle numbers for each
primer set were chosen as to yield a linear increase in product
(Table 1). Analysis of mRNA expression was accomplished by
obtaining the ratio of the band density of the gene product of
interest to that of GAPDH (a housekeeping gene) from the same
sample.
Use of inhibitors to determine signaling pathway(s) of HSP27
phosphorylation or induction
To determine whether inhibition of p38 MAPK, Akt, or ERK affects
HSP27 phosphorylation, LLC-PK1 cells were pretreated with an
inhibitor of p38 MAPK (20 mM, SB-203580), MEK1 (50 mM of PD-
98059), or PI3K (100 nM wortmannin) for 30 min before CCPA
treatment. Some cells were treated with inhibitors of signaling
intermediates to determine the effects of these inhibitors alone. The
doses of inhibitors were determined in preliminary experiments to
selectively block p38 MAPK, MEK1, or PI3K by preventing p38
MAPK, ERK1/2, or Akt phosphorylation, respectively.
Statistical analysis
The data were analyzed with Student’s t-test when comparing means
between two groups or with one-way analysis of variance plus
Tukey’s post hoc multiple comparison test to compare mean values
across multiple treatment groups. In all cases, a probability statistic
o0.05 was taken to indicate significance. All data are expressed
throughout the text as mean7s.e.m.
Protein determination
Protein content was determined with the Pierce Chemical
(Rockford, IL, USA) bicinchoninic acid protein assay reagent with
bovine serum albumin as a standard.
Materials
All drugs were in saline. Otherwise specified, all chemicals were
obtained from the Sigma Chemical Company (St Louis, MO, USA).
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